All lobbying filings

WALGREEN COMPANY

WALGREEN COMPANY filed a Q1 report for WALGREEN COMPANY on April 20, 2025.

Lobbying for WALGREEN COMPANY

All filings by WALGREEN COMPANY · Everything WALGREEN COMPANY has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 20, 2025

Expenses

$770,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Consumer Issues/Safety/Products

- Issues related to preventing organized retail crime

Taxation/Internal Revenue Code

- Issues related to tax reform

Pharmacy

- Issues related to access to pharmacist services - Issues related to increasing participation and diversity in clinical trials - Issues related to pharmacy benefit managers - H.R. 2484: Seniors Critical Access to Medications Act; issues related to pharmacist services - Issues related to 340B - Issues related to vaccine access

Bills named in this filing 1

H.R. 2484
Seniors’ Access to Critical Medications Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.